Latest period
$81.19B
YoY change
+14.1%
5Y CAGR
+5.2%
Peak year (2025)
$81.54B
Latest annual
$81.54B
Total Equity history chart for Johnson & Johnson (JNJ) from 1985 to 2025
Latest: $81.54B
Total Equity growth chart for Johnson & Johnson (JNJ) from 1985 to 2025
Latest: +14.1%
Total Equity history table for Johnson & Johnson (JNJ) from 1985 to 2025
| 2025 | $81.54B | +14.1% | +$10.05B | ||
| 2024 | $71.49B | +3.9% | +$2.72B | ||
| 2023 | $68.77B | -10.5% | −$8.03B | ||
| 2022 | $76.80B | +3.8% | +$2.78B | ||
| 2021 | $74.02B | +17.0% | +$10.74B | ||
| 2020 | $63.28B | +6.4% | +$3.81B | ||
| 2019 | $59.47B | -0.5% | −$281.00M | ||
| 2018 | $59.75B | -0.7% | −$408.00M | ||
| 2017 | $60.16B | -14.6% | −$10.26B | ||
| 2016 | $70.42B | -1.0% | −$732.00M | ||
| 2015 | $71.15B | +2.0% | +$1.40B | ||
| 2014 | $69.75B | -5.8% | −$4.30B | ||
| 2013 | $74.05B | +14.2% | +$9.23B | ||
| 2012 | $64.83B | +13.6% | +$7.75B | ||
| 2011 | $57.08B | +0.9% | +$501.00M | ||
| 2010 | $56.58B | +11.8% | +$5.99B | ||
| 2009 | $50.59B | +19.0% | +$8.08B | ||
| 2008 | $42.51B | -1.9% | −$808.00M | ||
| 2007 | $43.32B | +10.2% | +$4.00B | ||
| 2006 | $39.32B | +1.6% | +$608.00M | ||
| 2005 | $38.71B | +21.7% | +$6.90B | ||
| 2004 | $31.81B | +18.4% | +$4.94B | ||
| 2003 | $26.87B | +18.4% | +$4.17B | ||
| 2002 | $22.70B | -6.3% | −$1.54B | ||
| 2001 | $24.23B | +18.8% | +$3.84B | ||
| 2000 | $20.39B | +25.8% | +$4.18B | ||
| 1999 | $16.21B | +15.2% | +$2.14B | ||
| 1998 | $14.08B | +13.9% | +$1.72B | ||
| 1997 | $12.36B | +14.1% | +$1.52B | ||
| 1996 | $10.84B | +19.8% | +$1.79B | ||
| 1995 | $9.04B | +27.0% | +$1.92B | ||
| 1994 | $7.12B | +27.9% | +$1.55B | ||
| 1993 | $5.57B | +7.7% | +$397.00M | ||
| 1992 | $5.17B | -8.1% | −$455.00M | ||
| 1991 | $5.63B | +14.8% | +$726.00M | ||
| 1990 | $4.90B | +18.1% | +$752.00M | ||
| 1989 | $4.15B | +18.4% | +$645.00M | ||
| 1988 | $3.50B | +0.5% | +$18.00M | ||
| 1987 | $3.48B | +23.4% | +$660.80M | ||
| 1986 | $2.82B | -15.7% | −$526.70M | ||
| 1985 | $3.35B | — | — |
- 2025$81.54B+14.1%
- 2024$71.49B+3.9%
- 2023$68.77B-10.5%
- 2022$76.80B+3.8%
- 2021$74.02B+17.0%
- 2020$63.28B+6.4%
- 2019$59.47B-0.5%
- 2018$59.75B-0.7%
- 2017$60.16B-14.6%
- 2016$70.42B-1.0%
- 2015$71.15B+2.0%
- 2014$69.75B-5.8%
- 2013$74.05B+14.2%
- 2012$64.83B+13.6%
- 2011$57.08B+0.9%
- 2010$56.58B+11.8%
- 2009$50.59B+19.0%
- 2008$42.51B-1.9%
- 2007$43.32B+10.2%
- 2006$39.32B+1.6%
- 2005$38.71B+21.7%
- 2004$31.81B+18.4%
- 2003$26.87B+18.4%
- 2002$22.70B-6.3%
- 2001$24.23B+18.8%
- 2000$20.39B+25.8%
- 1999$16.21B+15.2%
- 1998$14.08B+13.9%
- 1997$12.36B+14.1%
- 1996$10.84B+19.8%
- 1995$9.04B+27.0%
- 1994$7.12B+27.9%
- 1993$5.57B+7.7%
- 1992$5.17B-8.1%
- 1991$5.63B+14.8%
- 1990$4.90B+18.1%
- 1989$4.15B+18.4%
- 1988$3.50B+0.5%
- 1987$3.48B+23.4%
- 1986$2.82B-15.7%
- 1985$3.35B—
Total Equity values are taken from Johnson & Johnson's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Equity at Johnson & Johnson (JNJ)
According to Johnson & Johnson's latest reported financial statements, the company's latest reported total equity is $81.19B. Net assets — also called stockholders' equity — equal total assets minus total liabilities. They represent the residual claim of shareholders on the company's assets and roughly track book value over time.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Johnson & Johnson (JNJ) reported total equity of $81.54B – grew 14.1% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Johnson & Johnson total equity compounded at +5.2% per year, sustaining 2 straight years of year-over-year growth.
The record annual total equity stands at $81.54B, reached in 2025; the historical low of $2.82B was recorded in 1986.
Johnson & Johnson Total Equity by Year
Johnson & Johnson Total Equity 2025: $81.54B
2025's total equity for Johnson & Johnson came in at $81.54B, grew 14.1% from 2024. This figure represents the highest annual value in the available history.
Johnson & Johnson Total Equity 2024: $71.49B
Johnson & Johnson posted total equity of $71.49B in 2024, edged up 3.9% from 2023.
Johnson & Johnson Total Equity 2023: $68.77B
In 2023, Johnson & Johnson reported total equity of $68.77B, declined 10.5% below 2022.
Johnson & Johnson Total Equity 2022: $76.80B
Johnson & Johnson total equity in 2022 was $76.80B, edged up 3.8% from 2021.
Johnson & Johnson Total Equity 2021: $74.02B
Johnson & Johnson total equity in 2021 was $74.02B.
See more financial history for Johnson & Johnson (JNJ).
Sector peers by Total Equity
Healthcare peers of Johnson & Johnson (JNJ), ranked by their latest total equity
| $94.11B | |
| $53.41B | |
| $52.61B | |
| $48.67B | |
| $30.52B | |
| $26.54B | |
| $8.66B | |
| −$3.27B |
- $94.11B
- $52.61B
- $48.67B
- $30.52B
- $26.54B
- $8.66B
- −$3.27B
Frequently asked questions
Johnson & Johnson (JNJ) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation